Skip to main content
. 2015 Jan 28;8(1):14–22. doi: 10.1093/ckj/sfu142

Table 2.

Strategies for translational nephrology

Development of novel diagnostic, risk stratification and individualization tools to personalize therapeutic approaches
Development of novel preventive and therapeutic approaches based on aetiologic and pathophysiological insights
Optimize clinical trial design and supportive structures
Optimize the scope and role of registries
Emphasize type 2 translation leading to widespread implementation and accessibility of proven medical approaches